Tirzepatide Inj shortage status
1 active shortage notice across 1 country.
Last updated 1 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Tirzepatide Inj
- Class
- Auto-created by FDA MedWatch — Drug Safety Alerts scraper
Where Tirzepatide Inj is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | high | 1 | 26 Feb 2026 | — | FDA MedWatch |
Why Tirzepatide Inj is in shortage
- regulatory action — e.g. “Lack of Assurance of Sterility” (United States)
Frequently asked questions
Is Tirzepatide Inj currently in shortage?
Yes. As of the latest regulator updates, Tirzepatide Inj has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Tirzepatide Inj in shortage?
Regulators attribute the current Tirzepatide Inj shortages to regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Tirzepatide Inj shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Tirzepatide Inj status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.